Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FG-4539 neuroprotective in stroke model

Feb. 15, 2007

Recent patents describe novel analgesic agents

Feb. 15, 2007

Recent patents describe new therapeutic agents for neurological disorders

Feb. 15, 2007

Lacosamide significantly reduces pain in peripheral diabetic neuropathy

Feb. 15, 2007

Adolor studies novel delta opioid receptor agonists

Feb. 14, 2007

Safety and efficacy of a transdermal Alzheimer's Abeta/CT vaccine shown in mice

Feb. 14, 2007

T-2000 improves essential tremor in two small studies

Feb. 14, 2007

Plethora studies PSD-597 as analgesic therapy in urogynecological procedures

Feb. 13, 2007

GSK and Fabre-Kramer sign global agreement for gepirone ER

Feb. 13, 2007

GSK and XenoPort sign agreement for XP-13512

Feb. 13, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...